Home

About US

Market Activity

World Indices

Market Watch

Coustumer Service

Learning Center

Economic Event

About US

Why Consider Us

Learn More About Us

Login

Premium Plan

Join Now

Tell a Friend

Help

Feedback

Contact Us

Member Profile

Forgot Password

Change Password

Stock Trading

Stock Trading Strategy

Technical Strategy

Breakout Stocks

Penny Stocks

401K Plan

401K Guide

401K Strategy

Learning Center

•    Relative Strength Index-RSI         •    Commodity Channel Index-CCI         •    Chaikin Money Flow -CMF         •    On Balance Volume - OBV         •   Price Rate of Change - ROC         •    Stochastic Oscillator-STO         •   % Price Oscillators-PPO

Affiliate Program

Resources

Disclaimer

 

CBST	CUBIST PHARMACEUTICALS INC COM
Sector Biotechnology & Drugs recommendations Buy BuyNear 23.54 StopLoss 17.82 PostedDate 11/2/2008 12:00:00 AM FirstRes 25.55 SecondRes 26.77 ThirdRes   FirstSupport 23.34 SecondSupport 17.82 Comments 11/2/2008 9:05:00 PM Biotechnology company Cubist Pharmaceuticals Inc.com (CBST) stock given a breakout on 10/31/08 with good volume again many technical indicators also have given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. Cubist Pharmaceuticals Inc.com (CBST) announced on 10/16/08 its third-quarter profit jumped 40 percent and Revenue increased 41 percent. Cubist Pharmaceuticals Inc.com (CBST) is a drug discovery company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. Cubist Pharmaceuticals Inc.com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $23.54 Top 5 Mid-Caps for Nov. 20 (at TheStreet.com)  (Wed, 19 Nov 2008 23:09:04 Etc/GMT) FDA panel: Theravance antibiotic safe, effective (AP) Federal health advisers on Wednesday said an antibiotic developed by Theravance appears safe and effective for fighting "superbug" bacteria, despite potential risks for pregnant women.(Wed, 19 Nov 2008 23:07:59 Etc/GMT) [$$] Recession or Not, We Still Need Drugs (at RealMoney by TheStreet.com)  (Mon, 17 Nov 2008 21:09:50 Etc/GMT) Top 5 Fast-Growth Stocks for Nov. 17 (at TheStreet.com)  (Mon, 17 Nov 2008 11:59:30 Etc/GMT) CUBIST PHARMACEUTICALS INC Financials (EDGAR Online Financials)  (Sat, 15 Nov 2008 14:04:17 Etc/GMT)
PETS	PETMED EXPRESS INC COM
Sector Retail (Drugs) recommendations Buy BuyNear 16.00 StopLoss 14.20 PostedDate 11/2/2008 12:00:00 AM FirstRes 17.72 SecondRes 19.50 ThirdRes   FirstSupport 15.97 SecondSupport 14.20 Comments 11/2/2008 9:06:46 PM PetMed Express Inc.com (PETS) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. PetMed Express Inc.com (PETS) announced on 10/20/08 its fiscal second-quarter profit climbed 29 percent PetMed Express Inc.com (PETS) is a pet-medication delivery company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. PetMed Express Inc.com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $16.00 Retail Industry (Zacks.com)  (Tue, 18 Nov 2008 21:27:53 Etc/GMT) These Stocks Are Still Growing (at Motley Fool)  (Tue, 18 Nov 2008 20:39:40 Etc/GMT) Seven Investment Candidates from the Forbes 'Best Small Companies' List (at Seeking Alpha)  (Mon, 17 Nov 2008 10:07:07 Etc/GMT) Top 5 Small-Caps for Nov. 14 (at TheStreet.com)  (Fri, 14 Nov 2008 11:59:51 Etc/GMT) Stock to Watch: PETS (at Seeking Alpha)  (Fri, 14 Nov 2008 10:14:09 Etc/GMT)
WSBC	WESBANCO INC COM
Sector Financial recommendations Buy BuyNear 27.18 StopLoss 25.46 PostedDate 11/2/2008 12:00:00 AM FirstRes 28.90 SecondRes 30.00 ThirdRes 31.45 FirstSupport 25.46 SecondSupport 22.56 Comments 11/2/2008 9:07:49 PM WesBanco, Inc. com (WSBC) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. WesBanco, Inc. com (WSBC) announced on 10/21/08 its net income increased 17.9% during the third quarter of 2008 WesBanco, Inc. com (WSBC) is a multi-state bank holding company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. WesBanco, Inc. com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $27.18 WESBANCO INC Financials (EDGAR Online Financials)  (Thu, 13 Nov 2008 14:04:54 Etc/GMT) WESBANCO INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)  (Thu, 6 Nov 2008 22:13:25 Etc/GMT) WesBanco Inc upgraded by Janney Mntgmy Scott (Briefing.com)  (Wed, 22 Oct 2008 14:21:20 Etc/GMT) WESBANCO INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online)  (Tue, 21 Oct 2008 21:19:44 Etc/GMT) WesBanco Announces Results for the Third Quarter and Nine Months of 2008 (PR Newswire) Paul M. Limbert, President and Chief Executive Officer of WesBanco, Inc. , a Wheeling, West Virginia based multi-state bank holding company, today announced earnings for the third quarter and year-to-date periods ended September 30, 2008.(Tue, 21 Oct 2008 20:51:00 Etc/GMT)
AMED	AMEDISYS INC COM
Sector Healthcare recommendations Buy BuyNear 55.13 StopLoss 46.55 PostedDate 11/2/2008 12:00:00 AM FirstRes 65.08 SecondRes 67.29 ThirdRes   FirstSupport 55.03 SecondSupport 46.55 Comments 11/2/2008 9:08:49 PM Amedisys Inc. com (AMED) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. Amedisys Inc. com (AMED) announced on 10/28/08 its profit grew 16 percent in the third quarter, and revenue jumped 78 percent. The company reported stronger admissions growth, and it was operating 150 more health agencies than a year earlier and also raised its full-year estimates, predicting greater profit and revenue Amedisys Inc. com (AMED) is a Home nursing company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. Amedisys Inc. com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $55.13 Premarket roundup: Financial cos., Limited Brands (AP) U.S. financial companies need an additional $1 trillion to $1.2 trillion in capital to restore confidence and improve liquidity, according to a Friedman, Billings, Ramsey analyst.(Thu, 20 Nov 2008 14:38:46 Etc/GMT) Ahead of the Bell: Amedisys downgraded (AP) A Deutsche Bank analyst downgraded shares of home nursing company Amedisys Inc. Thursday, pointing to concerns about a growing number of patients who aren't paying their bills.(Thu, 20 Nov 2008 14:07:40 Etc/GMT) AMEDISYS downgraded by Deutsche Securities (Briefing.com)  (Thu, 20 Nov 2008 11:55:13 Etc/GMT) Zacks #1 Rank Additions for Friday (Zacks.com)  (Fri, 14 Nov 2008 11:48:40 Etc/GMT) AMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)  (Wed, 12 Nov 2008 11:21:43 Etc/GMT)
EBS	EMERGENT BIOSOLUTIONS INC COM
Sector Biotech & Drugs recommendations Buy BuyNear   StopLoss   PostedDate 11/2/2008 12:00:00 AM FirstRes 18.19 SecondRes   ThirdRes   FirstSupport 16.11 SecondSupport 14.60 Comments 11/2/2008 9:09:46 PM Emergent BioSolutions Inc. com (EBS) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. Emergent BioSolutions Inc. com (EBS) announced on 10/1/08, it will receive between $364 million and $404 million for new contracts to supply the U.S. government with anthrax vaccines. Emergent BioSolutions Inc. com (EBS) is a Biotechnology company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. Emergent BioSolutions Inc. com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $18 Emergent BioSolutions to Webcast Presentation at the 6th Annual Southwestern Showcase Investor Conference on November 20, 2008 (Business Wire) ROCKVILLE, Md.----Emergent BioSolutions Inc. announced today that the company will be webcasting its presentation at the 6th Annual Southwestern Showcase Investor Conference sc